Inventor
Gediminas BRIZGYS
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
Y02ATechnologies for adaptation to climate change18%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
PatentTitleYear
12,415,808Pyrrolo[1,2-b]pyridazine derivatives202512,060,351Thiadiazole IRAK4 inhibitors202411,753,399Therapeutic compounds202311,702,414Thiadiazole IRAK4 inhibitors202311,572,362Pyrrolo[1,2-b]pyridazine derivatives202311,535,622Pyrrolo[1,2-b] pyridazine derivatives202211,267,801Therapeutic compounds2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to GILEAD SCIENCES INC (7)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 7 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |